Save time and get answers to complex questions with AI chat
Drugpatentwatch skyrizi biologic patent analysis?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Drugpatentwatch evista historical sales market context?Drugpatentwatch crizotinib?When is tenofovir alafenamide patent expiring?
See the DrugPatentWatch profile for vascepa
Vascepa (icosapent ethyl) is made by Amarin Pharma. They run the Vascepa Savings Card program, which covers copays for commercially insured patients. Eligible patients pay as little as $9 per 30-day supply (up to 13 prescriptions per year), with a maximum annual benefit of $117 per fill or $1,500 yearly. No income requirements apply, but it's limited to U.S. residents with private insurance. Apply online at vascepa.com/savings or by phone at 1-877-304-3181.[1]
Amarin's Patient Assistance Program (PAP) provides free Vascepa to uninsured or underinsured U.S. patients meeting income guidelines (typically ≤400-500% of federal poverty level, depending on household size). Submit an application via their website or call 1-877-304-3181. Processing takes 2-4 weeks, and approval lasts up to 12 months with annual renewal.[1][2]
Medicare Part D plans often cover Vascepa after prior authorization, with Extra Help (LIS) reducing copays to $4-$10 per fill for low-income enrollees. Medicaid state programs typically cover it fully for eligible patients. Check vascepa.com/support for plan-specific tools.[1]
Visit vascepa.com/patient-support or call 1-877-304-3181 to start. Provide proof of income, insurance denial (if applicable), and prescription. Most programs ship directly to pharmacies or doctors. Reapply periodically as benefits expire. Sources [1]: vascepa.com/patient-support [2]: amarin.com/patient-assistance [3]: rxassist.org [4]: needymeds.org [5]: pparx.org
Other Questions About Vascepa :